Academic and industry professionals at the forefront of San Diego’s life science community with a focus on innovation.
San Diego, CA
Joined March 2011
- Tweets50
- Following73
- Followers114
- Likes0
Life sciences execs say innovation may flee U.S. #billwalton speaks to Congress #connect #nuvasive nctimes.com/business/article…
@JohnCFierce I should have added a IMHO...Diekman no doubt has a role as well...but between those two I am sure there is leadership...
@JohnCFierce there are clear diffs-no articles comparing that I know of but committing 40M is a lot different than "announcing" 50M
@JohnCFierce spent the last week doing diligence on the burrill H1 2011 report that lists drug buddy deals in 2011..
Wondering which San Diegan investors/business leaders can boast attracting startups *TO* the region...bit.ly/oEbjL6
SparkBio retweeted
Great story - Amira bought by BMS today. Less than $30M in equity raised, sold for $325M upfront. Nice to see another 10x+ deal in biotech
@KeithDarce plenty that study the phenomenon of addiction but none come to mind that study vaccines as a treatment for dependency
@KeithDarce NABI's recent PIII tank makes this space a tough sell...nicotine vaccine was the best bet...
MT @ChristianeTrue: Whoah. Girlfriend of Medicis Corp. CEO found dead at his home. http://ow.ly/5EMoK http://ow.ly/5EMrc <-- super whoah
SparkBio retweeted
On @John_LaMattina's comments on Pfizer R&D cuts: Certainly agree, but it's not how much you got, it's how you use it >> http://j.mp/mQA7wu
SparkBio retweeted
So long as huge $ perceived as "winning," and not scientific advancement, #pharma R&D will continue to struggle.
SparkBio retweeted
Has bad management destroyed two generations of pharmaceutical research? My blog commenters are awfully smart: http://ow.ly/5wSQQ
MT"@JohnCFierce: reuters avastin story-insurers "likely" won't cover;devil worship would have a higher chance at reimbursement"<- hilarious